Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

N4 Pharma PLC (N4P)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.800 0.000    0.00%
03/05 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 198,696
  • Bid/Ask: 0.750 / 0.850
  • Day's Range: 0.750 - 0.800
Type:  Equity
Market:  United Kingdom
ISIN:  GB00BYW8QM32 
SEDOL:  BYW8QM3
N4 Pharma 0.800 0.000 0.00%

N4P User Rankings

 
Bellow, users are ranked according to the performance of their sentiments for the N4 Pharma PLC stock.
RankUsernameTotalClosedWinningWin %Chg. %
1Joe Higashi33133.33+365.41%
2Neil Parrish111100+237.58%
3Ahmed Mahomed55240+171.54%
4Patrick Vosseler77342.86+104.03%
5Darren Price111100+44.93%
6Andrew Robertson111100+23.13%
7Rani Miari111100+19.21%
8Dean Grande43133.33+7.16%
9Harj Ram22000%
10dan smyth1100-0.98%
11Stuart Harris22150-2.61%
12Stephen Thorman1100-16.87%
13Akhtar Ali2200-27.27%
14will saxby1100-29.01%
15john mather1010550-259.66%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

N4P Comments

Write your thoughts about N4 Pharma PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email